Ninety-three nasopharyngeal Haemophilus influenzae isolates were serotyped by two slide agglutination methods (SAST 1 and SAST 2) and the results compared with those obtained by capsule type-specific PCR. SAST 1 presented a low correlation with results obtained by PCR (75.2%) while SAST 2 showed a better agreement with the molecular technique results (93.5%). These findings suggest that SAST 2 could be an alternative method for adequate detection of H.influenzae type b.
Widespread use of Haemophilus influenzae type b (Hib) conjugate vaccines in industrialized countries has led to nearly complete elimination of Hib invasive diseases (6, 9, 12) . However, H. influenzae (Hi) remains an important etiological agent of meningitis, septicemia and pneumonia in infants from countries where the Hib vaccine is not accessible (9) . In regions where the availability of Hib conjugate vaccines is low, attendance at a day-care center (DCC) is recognized as a risk factor for invasive Hib disease (11) . DCC was and still is considered a risk factor, as reflected by the increased opportunities for the sharing of respiratory pathogens between children in such settings (3, 5, 8) .
Hi can express six capsule polysaccharides (serotypes a to f), traditionally identified by slide agglutination serotyping (SAST). Recently however, cases of misidentification of Hi serotypes by this method have been reported (1, 7) . To help to overcome this mishap, a SAST method (SAST 2) has been developed in the Adolfo Lutz Institute (1).
A PCR capsule typing method, developed by Falla et al. (4) , has been shown to present higher sensitivity and specificity than SAST. The first PCR reaction detected the bexA gene responsible for the transport of capsular material; its presence or absence determines whether an isolate is encapsulated or nonencapsulated and therefore, nontypeable (NTHi). The second PCR assay using capsule type specific primers (a to f) is then used to determine the capsule types of the isolates (1, 4, 7) . The aim of the present study was to verify the discrepancy between slide agglutination methods and the PCR method in the identification of the serotypes of Hi isolates from healthy carriers of the bacteria.
Between Nasopharyngeal samples obtained by using a twisted rayon tipped swab applicator (Copan, Brescia, Italy) in Amies media without charcoal, and plated on the same day, on a selective medium of 10% sheep blood-chocolate brain heart infusion agar plates, supplemented with 300 mg/L bacitracin (Difco Laboratories, Detroit, Michigan, USA). After incubation under a CO 2 -enriched atmosphere at 36ºC, plates were inspected for growth of Hi. Isolates were identified by colony and cell morphology and by the demonstration of growth requirements for Y and X factors (2). All strains were kept frozen at -80ºC in brain heart infusion broth (Difco) with 40% glycerol, until further analysis. Isolates were recovered from frozen samples by subculture on chocolate agar plates. Chromosomal DNA was obtained by the Pitcher et al. method (10) . Briefly, broth cultures were harvested at the end of the exponential growth phase by centrifugation, pellets were resuspended in Tris-HCl / EDTA buffer and cells were lysed with guanidium thiocyanate (Sigma) plus sarkosyl. DNA was extracted with ammonium acetate and cold isopropanol. A rapid DNA extraction method (7) was also performed; both DNA obtained were used for the PCR reactions to check results.
The isolates were blindly tested by three methods (SAST 1, SAST 2 and PCR). Each isolate was pre-tested with a 0.85% NaCl solution containing 0.5% formol to prevent autoagglutination. Monovalent serotype-specific rabbit antisera (specific for serotypes a through f), (Difco) were utilized. Method 1 (SAST 1) that uses a serotype b-specific antiserum for screening, was performed by suspending a full loop of bacterial growth into 50 µl of a serotype b-specific antiserum, and thoroughly mixed by rocking the slide for 1 min. In this method, the serotype b-specific antiserum was used for the initial screening; a positive agglutination result was considered to indicate serotype b. If the isolate was not reactive, it was tested with the remaining antisera (a through f). When a negative reaction towards all antisera in the set was observed, the strain was considered NTHi. Method 2 was performed with all antisera in parallel, as indicated in the Difco serological antiserum sheets: initially with Hi polyvalent antiserum and afterwards with Hi monovalent antisera type a to f, in parallel. For both SAST methods, the intensity of the reaction was recorded by symbols representing the absence of, or different grades of agglutination: (-, negative; +, slow and weak; ++++, rapid, with formation of large clumps). Positive agglutination was defined as the production of large clumps (+++ or ++++) with one specific antiserum only. The isolate was considered NTHi when negative agglutination results with the complete set of antisera or weak reactions with at least two antisera (nonspecific reaction) were observed. When positive agglutination occurred with at least two specific antisera, the isolate was considered polyagglutinated (1).
Primers specific for the bexA gene (primers H1 and H2) (4), required for capsular export, were used to differentiate NTHi from encapsulated isolates. Primers and PCR conditions have been previously described (4,7). Table 1 shows the prevalence of capsule types found among Hi by the three methods studied. Significant differences in the prevalence rates were found for capsule type b SAST 1 (25.8%) versus SAST 2 (1.1%) and PCR (1.1%) respectively. Also, divergent rates of NTHi isolates were identified by SAST 1 (74.1%) compared with SAST 2 (72.1%) and PCR (93.5%). Serotypes d, e and f were identified by SAST 2 but not by (Table 1 ).
These results demonstrate the limitations of SAST1 for Hi serotyping in comparison with the results provided by PCR. This difference was attributed to the use of a single type bspecific antiserum for screening, leading us to consider every form of agglutination as a Hib positive reaction, a finding complicated by the weak intensity of agglutination in the nasopharyngeal isolates from healthy subjects. Thus, SAST 1 overestimated the serotype b isolates, a finding which explains the poor agreement between SAST 1 and PCR for serotype b. This result is in accordance with those reported by La Claire et al. (7) and Bokerman et al. (1) . However, as previously reported (1) , the use of all antisera in parallel (SAST 2), significantly improved capsule type agreement with PCR.
The impact of the Brazilian program of Hib vaccination, initiated in 1999, should be evaluated among healthy children. We therefore stress the importance of using the SAST 2 method for the accurate estimation of H. influenzae type b in colonized children, and the use of PCR to confirm the results.
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RESUMO
Comparação de dois métodos de sorotipagem de cápsula por aglutinação em lamina e o método de PCR para a caracterização de sorotipos de Haemophilus influenzae Noventa e três isolados nasofaringeanos de H. influenzae foram sorotipados através de 2 métodos de aglutinação em lamina (SAST 1 e SAST 2) e os resultados foram comparados com a sorotipagem por PCR. SAST 1 apresentou uma baixa correlação com os resultados obtidos por PCR (75,2%) enquanto que SAST 2 mostrou uma melhor concordância com os resultados da técnica molecular (93,5%). Estes resultados indicam que SAST 2 pode ser um método alternativo para a correta detecção de H. influenzae tipo b.
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